Skip to main content
Year archive

NEUREN PHARMACEUTICALS LIMITED — 2008 filings

All 57 regulatory filings released by NEUREN PHARMACEUTICALS LIMITED (NEU) in 2008, sourced directly from the official regulator.

57 Filings
2008 Period
2008 filings (57)
Filing Released Lang
Neuren Announces Glypromate Trial Preliminary Results 3 pages ?Kb
Regulatory Filings
2008-12-23 English
Phase 3 trial data collection completed 1 page ?Kb
Regulatory Filings
2008-11-09 English
Appendix 4C - quarterly 6 pages ?Kb
Interim / Quarterly Report
2008-10-30 English
Neuren raises $2m through underwritten SPP 1 page ?
Capital/Financing Update
2008-09-29 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change
2008-09-29 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing
2008-09-29 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing
2008-09-29 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2008-09-29 English
US Army to provide additional NNZ2566 trial funding 2 pages ?Kb
Capital/Financing Update
2008-09-03 English
Half Yearly Report and Accounts 17 pages ?Kb
Interim / Quarterly Report
2008-08-28 English
Results of Special Shareholders` Meeting 1 page ?Kb
Declaration of Voting Results & Voting Rights Announcements
2008-08-27 English
Neuren signs cancer license and collaboration agreement 1
Capital/Financing Update
2008-08-26 English
Neuren extends SPP closing date 1 page ?Kb
Capital/Financing Update
2008-08-26 English
NZ Securities Act certification for SPP 1 page ?Kb
Capital/Financing Update
2008-08-20 English
Notice under section 708A(5)(e) of the Corporations Act 1
Capital/Financing Update
2008-08-14 English
Share Purchase Plan letter to eligible shareholders 6 pages ?Kb
Share Issue/Capital Change
2008-08-14 English
Notice of Special Meeting 9 pages ?Kb
Proxy Solicitation & Information Statement
2008-08-11 English
Change in substantial holding 2 pages ?Kb
Major Shareholding Notification
2008-08-11 English
Reinstatement to Official Quotation 1 page ?Kb
Capital/Financing Update
2008-08-05 English
Neuren raises a minimum of $3 million 2 pages ?Kb
Capital/Financing Update
2008-08-05 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2008-08-05 English
Neuren Share Purchase Plan 2 pages ?Kb
Capital/Financing Update
2008-08-05 English
Voluntary Suspension extended 1 page ?Kb
Capital/Financing Update
2008-08-03 English
Suspension from Official Quotation 2 pages ?Kb
Regulatory Filings
2008-07-30 English
Appendix 4C - quarterly 6 pages ?Kb
Interim / Quarterly Report
2008-07-30 English
Trading Halt 2 pages ?Kb
Capital/Financing Update
2008-07-28 English
Glypromate and NNZ 2566 in Top 10 Neuroscience Projects 2 pages ?Kb
Regulatory Filings
2008-07-20 English
NEU Completes Glypromate Phase 3 Recruitment 1 page
Regulatory Filings
2008-07-15 English
Neuren to get early results from Glypromate trial 2 pages ?Kb
Regulatory Filings
2008-06-29 English
CEO presentation to AGM 18 pages ?Kb
AGM Information
2008-05-28 English
Results of Meeting 1 page ?Kb
Declaration of Voting Results & Voting Rights Announcements
2008-05-28 English
Response to ASX Query re: Appendix 4C 4 pages ?Kb
Regulatory Filings
2008-05-25 English
Positive interim safety analysis for Glypromate 1 p
Capital/Financing Update
2008-05-14 English
Appendix 4C - quarterly 6 pages ?Kb
Interim / Quarterly Report
2008-04-29 English
Notice of Annual General Meeting/Proxy Form 7 pages ?Kb
AGM Information
2008-04-28 English
Quarterly Update to Shareholders April 2008 6 pages ?Kb
Management Reports
2008-04-28 English
Annual Report to shareholders 34 pages ?Kb
Annual Report
2008-03-30 English
Co-CEOs remuneration packages 1 page ?Kb
Remuneration Information
2008-03-17 English
Appendix 4E Preliminary Final Report 11 pages ?Kb
Annual Report
2008-02-28 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change
2008-02-25 English
Form 604 2 pages ?Kb
Major Shareholding Notification
2008-02-17 English
Becoming a substantial holder 3 pages ?Kb
Regulatory Filings
2008-02-12 English
Substantial shareholder notice 3 pages ?Kb
Regulatory Filings
2008-02-10 English
Rights issue raises $7.1m and notes convert 1 page
Capital/Financing Update
2008-02-10 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing
2008-02-10 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing
2008-02-10 English
Appendix 3B - allotment of rights issue underwriter shares 7 pages ?Kb
Capital/Financing Update
2008-02-06 English
Appendix 3B - shares issued on conversion of notes 7 pages ?Kb
Capital/Financing Update
2008-02-06 English
Change in substantial holding 2 pages ?Kb
Major Shareholding Notification
2008-02-06 English
Notice under section 708A(5)(e) 1 page ?Kb
Capital/Financing Update
2008-02-04 English
Appendix 3B - allotment of rights issue shares 7 pages ?Kb
Share Issue/Capital Change
2008-01-31 English
Results of Rights Issue 1 page ?Kb
Capital/Financing Update
2008-01-30 English
Neuren Appendix 4C December 2007 7 pages ?Kb
Interim / Quarterly Report
2008-01-30 English
US Department of Defense Approves NNZ2566 Funding 2 pages ?Kb
Capital/Financing Update
2008-01-20 English
Glypromate trial recruits 100th patient 2 pages ?Kb
Regulatory Filings
2008-01-16 English
Section 708AA Notice 2 pages ?Kb
Capital/Financing Update
2008-01-08 English
Neuren Confirms Despatch of Rights Issue Offer Documents 66 pages ?Kb
Capital/Financing Update
2008-01-08 English